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Despite much attention, the function of oligosaccharide chains on glycoproteins and glycolipids remains largely unknown.
Our understanding of oligosaccharide function in vivo has been limited to the use of reagents and targeted mutations that
eliminate entire classes of oligosaccharide chains. However, most biological functions for oligosaccharides have been
attributed to speci®c terminal sequences on these glycoside chains; yet, there have been few studies that examine the
consequences of modifying terminal oligosaccharide structures in vivo. To address this issue, mice were created bearing
a targeted mutation in b1,4-galactosyltransferase (GalTase), an enzyme responsible for elaboration of many of the proposed
biologically active carbohydrate epitopes. Most GalTase-null mice died within the ®rst few weeks after birth and were
characterized by stunted growth, thin skin, sparse hair, and dehydration. In addition, spermatogenesis was delayed, the
lungs were poorly developed, and the adrenal cortices were poorly strati®ed. The few surviving adults had puffy skin
(myxedema) and dif®culty delivering pups at birth (dystocia) and failed to lactate (agalactosis). All of these defects are
consistent with endocrine insuf®ciency, which was con®rmed by markedly decreased levels of serum thyroxine. The
polyglandular nature of the endocrine insuf®ciency is indicative of a failure of the anterior pituitary gland to stimulate
the target endocrine organs. Previous in vitro studies have suggested that incomplete glycosylation of anterior pituitary
hormones leads to the creation of hormone antagonists, which down-regulate subsequent endocrine function, producing
polyglandular endocrine insuf®ciency. In GalTase-null mice, the anterior pituitary acquired a normal secretory phenotype
during neonatal development indicative of normal glycoprotein hormone synthesis and secretion. However, as expected,
the gland was devoid of GalTase activity. These results support a requirement for terminal oligosaccharide sequences for
anterior pituitary hormone function. The fact that 10% of the GalTase-null mice survive the neonatal period indicates
the presence of a previously unrecognized compensatory pathway for glycoprotein hormone glycosylation and/or action.
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INTRODUCTION some of the many reagents that have been used to decipher
oligosaccharide function. From these studies, we suspect
Of the major classes of macromolecules, we know the that glycosides carry out a myriad of biological activities,
least about the most complex class, that of the glycoconju- impacting glycoprotein synthesis, transport, and stability;
gates. Their potential heterogeneity is greater than that of supramolecular organization; modulation of protein activ-
the nucleic acids, proteins, or lipids. However, our under- ity; intra- and intercellular protein traf®cking; and recogni-
standing of glycoconjugate function has been limited to in tion motifs for a variety of infectious agents, for cell±cell
vitro analyses, in which glycoside structure and/or expres- interactions and for cell±matrix interactions (Varki, 1993).
sion can be manipulated using a wide range of reagents. Although these in vitro analyses suggest that glycosides
Antibiotics, glycosidases, lectins, anti-carbohydrate anti- perform a multiplicity of functions, we still know very little
bodies, somatic cell mutants, and hapten inhibitors are just about the actual functions of glycoside residues in vivo.
The use of pharmaceuticals or mutations that block the
synthesis of entire oligosaccharide chains have con®rmed1 Present address: Department of Anatomy and Cell Biology, Em-
that glycosides are indeed required for normal developmentory University School of Medicine, Atlanta, GA 30322.
(Surani, 1979; Metzler et al., 1994; Ioffe and Stanley, 1994).2 Present address: Lexicon Genetics, Inc., The Woodlands, TX
77381. However, in vitro analyses suggest that the most biologi-
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were weighed once a week beginning on the day of birth. Eye colorcally relevant information is encoded in the terminal se-
and sex or pen labeling were used to distinguish pups until theyquences of glycoside chains. Unfortunately, there have been
were toe-cut and genotyped.only a few studies to date assessing the functional signi®-
cance of terminal carbohydrate sequences in vivo (Youakim
et al., 1994; Maly et al., 1996).
RT-PCRTo address this issue, mice were created that are null
forb1,4-galactosyltransferase (GalTase), one of the enzymes
Total tissue RNA was isolated with RNeasy reagent (Qiagen)responsible for the synthesis of many of the proposed biolog-
and quanti®ed by UV absorbance at 260 nm. One microgram ofically signi®cant epitopes. Surprisingly, the great majority
each RNA sample was random primed and reverse transcribed with
of GalTase-null mice survived embryogenesis, but died dur- Superscript II reverse transcriptase (BRL) at 427C for 50 min in the
ing the neonatal period. At least one of the primary defects presence of 11 ®rst strand buffer (BRL), 10 mM DTT, 0.5 mM each
responsible for the neonatal lethality appears to be a failure dNTP, and 5 U RNase inhibitor (Ambion). One-twentieth of
to galactosylate the glycoprotein hormones of the anterior synthesized cDNA from each sample was subjected to 100 ml of
PCR ampli®cation. The PCR reaction mixture was denatured atpituitary gland, leading to polyglandular endocrine insuf®-
947C for 5 min and ampli®ed for 35 cycles of 947C, 30 sec; 587C,ciency.
30 sec; 727C, 1 min. PCR products were fractionated on a 2% aga-
rose gel. Sense primer (5*-GGCGTCACCCTCGTCTATTA-3*) and
antisense primer (5*-ACGGAATGGGATGATGATGG-3*) corre-MATERIALS AND METHODS spond to the 104th and 559th nucleotides, respectively, of the
cDNA, relative to the ®rst ATG. In some instances, primers were
Targeting Vectors and Homologous Recombination used to assess the presence of sequences encoding the COOH-
terminal catalytic domain (sense: 5*-AAGGCATGTCTATAT-
Genomic DNA for mouse GalTase was isolated from a genomic CACGT-3*; antisense: 5*-TGTCCCGATGTCCACTGTGA-3*) cor-
DNA library (Stratagene) prepared from strain 129/Sv using a 32P- responding to the 974th and 1191st nucleotides, respectively, of
labeled 531-bp cDNA fragment corresponding to exon 1 of GalTase the cDNA, relative to the ®rst ATG. b-actin primers (sense: 5*-
as probe (Lopez et al., 1991). An 8-kb EcoRI±SalI fragment spanning TGTGATGGTGGGAATGGGTCAG-3*; antisense: 5*-TTTGAT-
the ®rst exon (Hollis et al., 1989) was subcloned into pKS(0) plas- GTCACGCACGATTTCC-3*) were included in all reactions, pro-
mid vector, from which the gene targeting vector was constructed. ducing a 514-bp fragment as an internal control.
A PGK-neo expression cassette was inserted in reverse orientation
into the ClaI±NotI sites and served as a positive selection marker
as well as a mutagen. A negative selection marker, the herpes sim-
Analysis of GalTase Activity and Reaction Productplex virus thymidine kinase (HSV-tk) gene, was inserted into the
targeting vector outside of the homologous region to allow selec-
Tissues were isolated from wild-type and gt 0/0mice at 4 weekstion against cells that underwent nonhomologous integration
of age, homogenized on ice in 0.5 ml of medium B, and assayed(Mansour et al., 1988). Targeting vector was transfected into AB1
for GalTase activity toward endogenous and exogenous (i.e., N-embryonic stems (ES) cells (McMahon and Bradley, 1990), and ho-
acetylglucosamine) substrates as described (Shur, 1982).mologous recombination events were screened from the drug-resis-
To determine the glycosidic linkage of the 3H-galactosylated re-tant ES population by using a 1.1-kb StyI fragment as a 5*-external
action product in testis or brain homogenates, equal cpm of productprobe. The targeted ES clones were microinjected into blastocysts
were treated with Streptococcus pneumoniae b1,4-galactosidaseof 3.5-day C57BL/6J embryos that further developed to chimeras
(Oxford GlycoSystems) in a volume of 50 ml reaction containing(Bradley, 1987). Chimeric animals were mated to C57BL/6J to cre-
the indicated amount of enzyme. The reaction was incubated atate heterozygous animals that were intercrossed to generate homo-
377C for 2 hr. Remaining 3H products were determined by high-zygous animals.
voltage borate electrophoresis as described (Shur, 1982).
The presence of terminal b1,4-galactosyl residues in tissue ly-
sates was determined by either lectin blotting or reactivity towardAnalysis of Viability
a2,6-sialyltransferase. For lectin blotting, 6 mg of each sample were
heat-inactivated at 857C for 10 min and divided into three groups.Heterozygous females were housed with one heterozygous male.
The plug day was considered to be E0.5. Fetal viability was deter- One group was incubated without enzyme (control). The other two
groups were incubated with 20 mU of Clostridium perfringensmined by embryonic movement in response to stimulus or by the
presence of a beating heart. Embryos (E18.5), newborn pups, and neuraminidase (Sigma) at 377C for 6 hr, after which the neuramini-
dase was heat-inactivated and cooled. One of these groups wasneonatal pups were genotyped by Southern analysis (Sambrook et
al., 1989) using the 1.1-kb StyI fragment as probe and by PCR analy- further incubated at 377C overnight with 4 mU of b1,4-galactosi-
dase. Two micrograms of each sample was loaded on each slot ofsis using primers that distinguished the wild-type (301-bp PCR
product) and mutant (243-bp PCR product) alleles [wild-type allele: Hybond-N/ membrane (Amersham). The blots were labeled with
RCA-I lectin speci®c for terminal b1,4-galactosyl residues (Nicol-5*-primer: 5*-ACACTCCCGCCCCCCCAGGTT-3*, 3*-primer: 5*-
GCTCACGAAACCTAAGCTTCCCGCC-3, corresponding to the son and Blaustein, 1972) following the manufacture's instructions
(Vector).0286th and 15th nucleotides, respectively, relative to the ®rst Gal-
Tase ATG codon; mutant allele: 5*-primer: 5*-GGTGGATGTGGA- Alternatively, tissue homogenates were treated with either neur-
aminidase or b1,4-galactosidase as above prior to incubation withATGTGTGCGAGG-3*, corresponding to the 0401st nucleotide in
the pgk-1 promoter of the neo cassette (Ada et al., 1987), 3*-primer: a2,6-sialyltransferase (Sigma). Treated samples were incubated at
377C for the indicated time in the presence of 0.5 mU sialyltransfer-5*-AGAAGCTGCACCAGGGCTGGA-3*, corresponding to the
318th nucleotide, relative to the ®rst GalTase ATG codon]. Pups ase and 0.2 mCi of CMP-3H-NeuAc (Dupont-NEN) for each time
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FIG. 1. Generation of GalTase-de®cient mice. (a) Targeted disruption of the mouse GalTase gene by homologous recombination. Sche-
matic diagrams show the wild-type GalTase allele (top), the replacement vector (middle), and the predicted targeted mutated allele (bottom).
Exon 1 includes the two ATG codons for translation of the two GalTase isoforms. The targeting construct was prepared from an 8.0-kb
fragment of 129/Sv genomic DNA. After recombination (crossed arrows), the PGK-neo expression cassette replaces a 1.9-kb fragment
containing the coding region for the entire cytoplasmic and transmembrane domains and a portion of the catalytic domain. (b) Tail DNA
from neonatal pups was digested with PstI, fractionated on 0.8% agarose, transferred to Hybond-N/ membrane, and probed with a 32P-
labeled StyI fragment diagramed in (a). PstI fragments re¯ecting the wild-type (6.7 kb) and mutant (5.6 kb) alleles are shown.
point. The labeled products were analyzed by high-voltage borate genomic GalTase DNA encoding the complete cytoplasmic
electrophoresis as described (Shur, 1982). and transmembrane domains of GalTase and a portion of
the extracellular stem region (Russo et al., 1990). The neo
insertion also disrupted the reading frame of the remainingHistology
GalTase sequences.
Tissues were isolated from 3-week-old mice, ®xed, embedded in Five independent ES clones (1.6%) were identi®ed that
paraf®n, and sectioned using routine histological procedures. Five underwent homologous recombination as determined by
micrometer sections were stained with hematoxylin and eosin or Southern analysis. Two independent ES clones bearing the
with Heidenhain's aniline blue stain (Thompson, 1966). targeted GalTase allele were transmitted through the germ
line after embryo injection. There were no obvious defects
in heterozygous mutant mice (gt //0), which were crossedThyroxine RIA
to produce homozygous mutant animals (gt0/0). Litter size
Mice were sacri®ced by carbon dioxide asphyxiation and blood averaged 6.9 pups, and the genotypes of all animals were
was withdrawn by cardiac puncture. Serum was collected, frozen, determined by Southern (Fig. 1b) or PCR analysis.
and shipped to Ani Lytics (Gaithersburg, MD) for T4 and T3 assays.
Most GalTase-null Mice Are Neonatal Lethals
RESULTS
The majority of homozygous mutant mice progressed
through embryonic development, since 22.7% of 18.5-day-Creation of GalTase-null Mice
old embryos were gt 0/0. However, homozygotes died soon
after birth and during the subsequent 2±3 weeks (Fig. 2a).GalTase was inactivated in AB1 embryonic stem (ES) cells
by introduction of the neo selectable marker into the ®rst Only 10% of gt 0/0mice (2.6% of total mice) survived this
period of neonatal lethality. All gt 0/0mice showed a simi-exon of GalTase (Fig. 1a). The neo cassette replaced 1.9 kb of
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was examined in multiple tissues from gt 0/0 animals.
Tissues assayed included salivary gland, stomach, adrenals,
small intestine, pancreas, testis, spleen, lung, thymus, liver,
kidney, heart, brain, and skeletal muscle. RT-PCR of se-
quences within exon 1 demonstrated the loss of the GalTase
mRNA in all tissues (Fig. 3a). The integrity of all RNA
samples was con®rmed through the use of PCR primers for
b-actin.
GalTase enzyme activity was undetectable in all gt 0/0
tissues except testis and brain, which exhibited 4 and 30%,
respectively, of wild-type enzyme activities (Fig. 3b). Al-
though the residual activity in gt 0/0 testis and brain re-
¯ects different percentages of wild-type activity in these
organs, their speci®c activities were very low and similar
to one another (100 cpm 3H-Galb1,4GlcNAc product/25
mg prt/hr). The galactosylated product in both testis and
brain was partially sensitive to digestion with b1,4-speci®c
galactosidase from S. pneumoniae, suggesting the presence
of authentic GalTase-like activity in these two tissues. The
residual b1,4-galactosidase-resistant material in brain, but
not testis, was sensitive to digestion by bovine testis galac-
tosidase, which hydrolyzes b1,4-, b1,3-, and b1,6-galactosyl
residues (Sheares et al., 1982). This indicates the presence
of other non-b1,4-galactosyltransferase activities toward
GlcNAc (e.g., Galb1,3GlcNAc) in brain lysates (data not
shown). Tissues from gt //0 heterozygotes showed inter-
mediate levels of enzyme activity (data not shown).
We examined the possibility that the low levels of resid-
ual GalTase-like activity in brain and testis resulted from
cryptic promoter activity in the inverted neo cassette. Even
in the absence of the cytoplasmic and signal sequence/trans-
membrane domains, it is conceivable that such transcripts
could permit translation from downstream AUGs leading
to low levels of a soluble, catalytic domain. PCR analysis
FIG. 2. Viability of GalTase homozygous null mice. (a) The major- of 3*-COOH-terminal sequences encoding the catalytic do-
ity of gt 0/0 embryos develop to term as judged by their presence main showed low and variable levels of these sequences in
at 18.5 days of gestation [22.7% observed (22/97) vs 25% expected].
testis (data not shown). However, it is not known if theseSome newborn pups were lost during or soon after delivery as indi-
sequences are, in fact, translated, which would account forcated by the open line between Day 01 (E18.5) and Postnatal Day
the low level of enzyme activity. Furthermore, we can not2, however, most gt 0/0 pups died during neonatal development.
eliminate the possibility of a novel b1,4-galactosyltransfer-The theoretical viability of wild-type pups is indicated by the
dashed line. (b) Only 10% of gt 0/0 mice (2.6% of total) survive ase gene product responsible for this low level of activity.
past the neonatal period, after which they grow at normal rates. The presence or absence of GalTase activity in gt 0/0
Values represent the mean weight {SE of four wild-type (s) and mice was further examined by analyzing tissue homoge-
three gt 0/0 (l) males. A male pup who died at 17 days of age is nates for the presence of the GalTase product, i.e., b1,4-
also shown (dashed line).
galactosyl residues. Reactivity toward RCA-I lectin and
a2,6-sialyltransferase was assayed, since both preferentially
recognize terminal b1,4-galactosyl groups (Nicolson and
Blaustein, 1972; Paulson et al., 1977). RCA-I-reactive glyco-lar phenotype as described below, including stunted growth
conjugates were readily detectable in tissues from wild-typeand defective skin and hair. Surprisingly, those that survived
animals; representative results are shown for intestine,the neonatal period recovered a normal growth rate and over-
heart, testis, and lung (Fig. 4a). RCA-I reactivity was in-all appearance between 3 and 4 weeks of age (Fig. 2b).
creased following neuraminidase treatment (N) to expose
additional b1,4-galactosyl groups and was eliminated by
Analysis of GalTase mRNA, Activity, and Reaction treatment with b1,4-speci®c galactosidase (G), as expected
Product for authentic RCA-I reactivity. Similarly, wild-type tissues
had substrate activity (i.e., terminal b1,4-galactosyl resi-The expression of both GalTase mRNA and enzyme ac-
tivity toward N-acetylglucosamine (GlcNAc) substrates dues) toward a2,6-sialyltransferase, which was eliminated
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FIG. 3. Characterization of GalTase expression. (a) RT-PCR analysis of GalTase expression in various tissues. GalTase-speci®c ampli®ca-
tion of a 456-bp fragment was detected in all wild-type tissues (/), but not in gt 0/0 tissues (0). Primers for b-actin were used to assess
the integrity of the RNA samples. (b) GalTase activity in wild-type (open symbols) and gt 0/0 (®lled symbols) tissues. Enzyme activity
was undetectable in all gt 0/0 tissues, except testis and brain, which exhibited 4 and 30%, respectively, of wild-type enzyme levels.
Tissues with similar speci®c activities are graphed together. (c) Approximately 70% of the 3H-galactosylated product in gt 0/0 testis and
brain was sensitive to b1,4-galactosidase digestion, indicating the presence authentic GalTase activity in these tissues, although of very
low speci®c activity.
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FIG. 4. Analysis of GalTase reaction product. (a) RCA-I reactivity of tissue homogenates. RCA-I speci®cally recognizes Galb1,4GlcNAc
linkages and binds to glycoconjugates in tissue homogenates from wild-type (/) mice. Tissue homogenates were reacted with RCA-I under
one of three conditions: either without prior treatment (middle), or following neuraminidase treatment (N) to expose b1,4-galactosyl
groups, or following b1,4-galactosidase (G) digestion to remove b1,4-galactosyl groups. Most tissues from gt 0/0 (0) animals failed to
react with RCA-I even after neuraminidase treatment to expose potential b1,4-galactosyl groups. However, neuraminidase treatment
exposed reactivity in lung. Negative (0, carboxypeptidase Y) and positive (top /, fetuin; bottom /, asialo-fetuin) control proteins are
included. (b) Detection of terminal b1,4-galactosyl groups by reactivity to a2,6-sialyltransferase. Homogenates of wild-type (s) stomach
are shown to illustrate reactivity to sialyltransferase, whereas gt 0/0 (l) stomach had no reactivity. Wild-type reactivity was sensitive
to pretreatment with b1,4-galactosidase (dashed lines), indicative of authentic b1,4-galactosyl groups. In contrast, salivary gland homoge-
nates from both wild-type (s) and gt 0/0 (l) mice had similar reactivity to sialyltransferase, all of which were eliminated by pretreatment
with b1,4-galactosidase (dashed lines), thus suggesting an alternative pathway for b1,4-galactosylation in salivary gland.
FIG. 5. Phenotypic analysis of GalTase-de®cient mice. (a, b) Views of 3-week-old wild-type and gt 0/0 C57BL/6J black and albino mice.
The gt 0/0 mice (right of each pair) are dwarf with sparse hair and thin skin. Note the intestinal contents visible through the albino skin
as is the scalp; the hair is missing on the dorsal neck of the black gt 0/0 animal. (c, d) Sections through age-matched dorsal, thoracic±
lumbar skin from wild-type (c) and gt 0/0 (d) mice. Note the reduced development of hair follicles and subdermal adipose tissue. (e, f)
Sections of testis from wild-type (e) and gt0/0 (f) males. Spermatogenesis is delayed in the mutant as evidenced by the smaller seminiferous
tubules and by the predominance of pachytene spermatocytes in gt 0/0 mice (arrowhead) relative to the predominance of round and late
spermatids in wild-type (arrowhead). (g, h) Sections through lungs of newborn wild-type (g) and gt 0/0 (h) mice. Note the thick trabeculae
in gt 0/0 and the smaller alveoli as compared to wild-type. (i) Views of dissected whole adrenal glands from wild-type (left) and gt 0/0
(right) mice. (j, k) Sections of adrenal glands through their widest diameter (equator) illustrating the reduced size and strati®cation of the
adrenal cortex. Most conspicuous is the dramatically reduced differentiation of the inner zona reticularis and intermediate zona fasciculata.
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by pretreatment with b1,4-speci®c galactosidase; results for
stomach and salivary gland are shown (Fig. 4b).
Some tissue homogenates from gt0/0mice retained vari-
able amounts of reactivity toward RCA-I and/or a2,6-sialyl-
transferase, indicative of either residual GalTase activity or
alternative pathways for b1,4-galactosylation. For example,
neuraminidase treatment of gt 0/0 lung lysates exposed
cryptic RCA-I reactivity (Fig. 4a). gt0/0 salivary glands had
normal levels of reactivity toward a2,6-sialyltransferase,
the product of which was sensitive to b1,4-speci®c galactos-
idase digestion (Fig. 4b). Intestinal lysates also showed very
low levels of residual b1,4-galactosyl groups by both RCA-
I and a2,6-sialyltransferase reactivity (data not shown).
Endocrine Insuf®ciency in GalTase-null Mice
The gt 0/0 animals that survived the ®rst week grew
much slower than wild-type or heterozygous littermates.
Their hair was sparse (Figs. 5a and 5b) and the skin was
often thin enough to allow visualization of the intestinal
contents (Fig. 5b). The reduced size and defective skin and FIG. 6. GalTase-de®cient mice have reduced serum levels of thy-
hair are indicative of endocrine insuf®ciency, particularly roxine. T4 levels are greatly reduced in 3-week-old gt 0/0 (0/0)
hypothyroidism (Wilson et al., 1991). Histological examina- mice relative to wild-type (///) littermates (shaded bars). A pair
of females and a pair of males are shown out of a total of ®ve pairstion revealed marked reduction in the density of hair folli-
assayed; all produced similar results. Serum levels of T3 were alsocles and subdermal adipose tissue (Figs. 5c and 5d). Further
reduced in gt 0/0mice (data not shown). T4 levels return to controlevidence for endocrine insuf®ciency is the delayed sperma-
values (hatched bars) in males that survive the neonatal period (4togenesis in the testis (Figs. 5e and 5f), the poorly differenti-
weeks of age).ated lung parenchyma containing thick septa and small al-
veoli (Figs. 5g and 5h), and the reduced size (Fig. 5i) and
strati®cation (Figs. 5j and 5k) of the adrenal cortex. All other
tissues examined histologically appeared normal, including pituitary appeared normal in size (Fig. 7a). The protein mass
of isolated, intact pituitaries (i.e., anterior, intermediate,salivary gland, stomach, intestine, pancreas, spleen, thy-
mus, liver, kidney, heart, and skeletal muscle, although and posterior lobes) from gt 0/0 mice was only 32% that
of wild-type littermates (11.4 mg protein/15-day pituitarythey all were reduced in overall size. The brain appeared
grossly normal in size. vs 35.8 mg protein). However, despite its reduced size in
neonates, the constituent cells of the anterior pituitary hadIn addition to the physical and histological phenotype
seen in the neonates, the few surviving adults demonstrated a characteristic chromophilic phenotype indicative of active
hormone secretion (as in Fig. 7b). This was con®rmed bypuffy faces (hypothyroid myxedema), an inability to deliver
pups (dystocia), and an inability to lactate (agalactosis). Col- detecting TSH and GH in serum of 14- to 21-day-old gt
0/0 mice (unpublished observations).lectively, this spectrum of neonatal and adult phenotypes
is indicative of the syndrome of polyglandular endocrine In newborn mice, the anterior pituitary appeared develop-
mentally delayed, since the cells in gt 0/0mice were chro-insuf®ciency (Gill, 1991). As a marker of endocrine insuf®-
ciency, serum levels of thyroxine (T4) were assayed; levels mophobic with clumped nuclei and little cytoplasm, indica-
tive of a quiescent, poorly secretory phenotype (Snell, 1984)were dramatically reduced in all gt 0/0 mice that were
examined, compared to control littermates (Fig. 6). Consis- (Fig. 7c). Whether the developmental delay of the anterior
pituitary is a primary effect of the GalTase de®ciency, or istent with this contributing to the neonatal gt 0/0 pheno-
type, thyroxine levels returned to normal in those animals a secondary effect of dwar®sm, is unknown. Nevertheless,
the cells of the anterior pituitary acquired a normal secre-that survived the neonatal period (Fig. 6). Serum levels of
T3 showed a similar trend (data not shown). Liver enzymes tory phenotype during neonatal development, at which
time the mice showed characteristic polyglandular endo-were elevated approximately twofold, consistent with endo-
crine insuf®ciency, as was the marked dehydration of the crine insuf®ciency.
It was of interest, therefore, to determine whether thehomozygous null mice prior to death.
Polyglandular endocrine insuf®ciency is most often asso- glycoprotein hormones secreted by the anterior pituitary in
gt0/0mice lacked the characteristic terminal disaccharide,ciated with dysfunction of the anterior pituitary, the gland
responsible for the synthesis of the hormones that stimulate sialic acid±galactose. The limited volume of serum ob-
tained from 14-day-old pups precluded this analysis. As anthe target endocrine glands (Gill, 1991). In gt 0/0mice, the
anterior pituitary gland was reduced in size, as were most alternative, GalTase activity was assayed directly in pitu-
itaries isolated from gt 0/0 and control littermates, espe-of the other organs described above (Fig. 7a). The posterior
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cially in light of the low levels of residual GalTase-like hypogonadal function; however, the GalTase-null mouse has
reduced anterior pituitary size and is neonatal lethal.activity in total brain homogenates (Fig. 3b). As expected,
pituitaries isolated form gt0/0 animals were totally devoid Although the elimination of GalTase activity in the ante-
rior pituitary can readily account for the polyglandular endo-of GalTase activity (///: 2294 cpm 3H-Galb1,4GlcNAc
product/25 mg prt/hr vs 0/0: background cpm). Thus, the crine insuf®ciency, it is surprising that the anterior pituitary
is reduced in size in the gt 0/0 neonate. In fact, one wouldhormones themselves appeared to be made normally, at
least in proportion to the size of the pituitary, as evidenced expect that the lack of circulating thyroid and gonadal hor-
mones would result in hyperplasia of the anterior pituitaryby their presence in serum and by the chromophilic, secre-
tory phenotype of the anterior pituitary cells. However, the as is seen in the a-subunit null mouse (Kendall et al., 1995).
Whether this results from delayed hypothalamic stimulationcomplete lack of GalTase activity would result in hormones
with incompletely glycosylated side chains. of the anterior pituitary or due to a previously unde®ned
autocrine feedback loop awaits further investigation.
As expected, most tissues were devoid of b1,4-galactosyl
residues. Some tissues (lung, intestine, and salivary gland),DISCUSSION
however, had residual b1,4-galactosyl groups as judged by
RCA-I and a2,6-sialyltransferase reactivities. Similarly, re-Results presented here show that the elimination of Gal-
Tase activity from mice leads to polyglandular endocrine sidual b1,4-galactosyltransferase-like activity toward free
GlcNAc substrates was detectable in brain and testis. RT-insuf®ciency. There was no evidence of any other histologi-
cal abnormality that could account for the neonatal lethal- PCR analysis suggested that these low speci®c activities
may have resulted from inappropriate transcription fromity. In this regard, we failed to detect any evidence of intesti-
nal epithelial pathology in gt 0/0 mice, as suggested by the neo cassette, allowing translation from downstream
AUG codons. We can not eliminate the possibility, how-others in preliminary reports (Asano et al., 1996).
The polyglandular endocrine insuf®ciency is most readily ever, that these low activities re¯ect a unique polypeptide
or that an alternative tissue-speci®c pathway for b1,4-galac-explained by the incomplete glycosylation of the anterior
pituitary hormones (Baenziger and Green, 1988; Thotakura tosylation may exist that has not been previously recog-
nized. A unique glycolipid galactosyltransferase has beenand Blithe, 1995). The pituitary hormones TSH, FSH, and
LH, as well as chorionic gonadotropin, are heterodimers identi®ed and cloned, but this enzyme catalyzes the transfer
of galactose from UDPGal to ceramide, rather than tocomposed of a common a subunit and a hormone-speci®c
b subunit. Both subunits have N-linked oligosaccharide GlcNAc (Schulte and Stoffel, 1993). To date, the only mam-
malian gene product known to synthesize the Galb1,4Glc-chains; some are of the complex-type bearing terminal sialic
acid±galactose±GlcNAc trisaccharides, whereas others NAc linkage is the GalTase gene inactivated in this study.
Interestingly, preliminary reports suggest that the chickenhave an unusual sulfated N-acetylgalactosaminyl (GalNAc)
residue (Baenziger and Green, 1988; Thotakura and Blithe, genome contains two distinct functional GalTase genes
(Shaper et al., 1995).1995). The sulfated GalNAc moiety has been shown to be
critical for clearance of the circulating hormone by hepatic The availability of GalTase-de®cient mice now allows
the utilization of these animals and derivative cell lines toreceptors that recognize this sulfated epitope (Fiete et al.,
1991). In contrast, the sialylated oligosaccharides on the a explore previously unapproachable problems in glycobiol-
ogy in which b1,4-galactosyl residues are thought to be criti-subunit, particularly those linked to Asn-52, are thought to
be important for activating adenylate cyclase in the target cal. Among these, ®broblasts from galactosemic patients
and immunoglobulin chains from rheumatoid arthritic pa-cell (Sairam and Bhargavi, 1985; Flack et al., 1994). In vitro
studies have shown that incomplete glycosylation of the tients are characterized by incomplete b1,4-galactosylation
(Ornstein et al., 1992; Tsuchiya et al., 1994). Fibroblastspituitary hormones results in the creation of hormone an-
tagonists that can bind to their respective receptors, but are and blood cells from GalTase-de®cient mice can determine
whether these syndromes are associated with unique Gal-unable to activate adenylate cyclase. In this regard, sequen-
tially removing terminal monosaccharide residues in vitro Tase-like activities or they may serve as useful animal mod-
els for these diseases. De®cient glycosylation of the selectinhas shown that b1,4-galactosyl moieties are required for
adenylate cyclase activation (Moyle et al., 1975). ligands (i.e., sialyl Lewis X epitopes) on endothelial and
blood cells in GalTase-de®cient mice should result in phe-These results suggest that the anterior pituitary hormones
in gt0/0 animals most likely behave as biologically inactive nocopies of LAD 2 (leukocyte adhesion de®ciency type 2)
syndrome, analogous to that produced by targeted muta-receptor antagonists leading to hypogonadal and hypothyroid
function. Interestingly, other pituitary hormones, e.g., ACTH tions in the selectins themselves (Frenette et al., 1996) or
in the a1,3-fucosyltransferase responsible for synthesizingand prolactin, are also glycosylated and recent evidence sug-
gests that their degree of glycosylation impacts their biological the selectin ligand (Maly et al., 1996). Furthermore, these
animals can also be used to isolate GalTase-de®cient cellactivity (Skelton et al., 1992; Hoffman et al., 1993). It is of
interest that the phenotype of the GalTase-null mouse is quite lines that thus far have been refractory to lectin-based selec-
tion procedures.similar to that produced by a targeted mutation in the a sub-
unit of the pituitary hormones (Kendall et al., 1995). Both It is noteworthy that GalTase-de®cient animals progress
through embryogenesis apparently normally, although wenull mutations produce dwarf animals with hypothyroid and
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FIG. 7. (a) Views of isolated pituitary glands from wild-type (left) and gt 0/0 (right) mice. The gt 0/0 anterior pituitary is greatly reduced
in size and is much thinner as evident by the transillumination through the tissue. In contrast, wild-type tissue is larger and thicker,
with a ¯eshy appearance. The posterior lobes (arrowheads) are similar in size in both animals. (b, c) In newborn pups, the cells of the
anterior pituitary appear richly acidophilic (arrows) in wild-type (b), whereas gt 0/0 cells are clumped together and nonsecretory (c).
However, gt 0/0 glands acquire a normal secretory phenotype similar to that seen in (b) during neonatal development.
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